{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:17:00Z","timestamp":1788542220365,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Despite the critical role of clinical trials in advancing cancer treatment, patient enrollment remains low at less than 10% with various health system-, provider-, and patient-level barriers [1]. This study explored perspectives of patients with breast cancer receiving treatment who declined clinical trial participation to work towards developing more effective, patient-centered recruitment strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This qualitative study enrolled patients who were offered participation in a breast cancer clinical trial yet declined to participate from August 2023 to March 2024. Semi-structured interviews were used to elucidate patient perspectives on the clinical trial recruitment process. An open coding scheme was used to identify major themes present throughout the transcribed interviewers. Two independent reviewers then coded using NVivo 14 software with a third reviewer to settle any discrepancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 21 female patients interviewed, 43% had previously declined enrollment onto a therapeutic clinical trial and 57% a non-therapeutic clinical trial. Three core themes regarding patient-suggested strategies to optimize clinical trial recruitment emerged: (1) improving communication with patients (e.g., ensuring presentation of key information, timing of recruitment, manner of information delivery, provider involvement), (2) increasing accessibility\/availability of resources to address logistical burdens (e.g., ride-share, telehealth, compensation), and (3) leveraging media in recruitment platforms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights critical areas for optimization of clinical trial recruitment offering strategies such as the use of lay patient navigators, physician\/researcher recruitment training in communication and implicit biases, and mixed\/online recruitment. This feedback can better inform more patient centric recruitment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10552-026-02140-5","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:35:27Z","timestamp":1771493727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Strategies for optimizing clinical trial recruitment: perspectives among patients with breast cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"Mandy","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Reh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu R.","family":"Dwarampudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney P.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle B.","family":"Rocque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Gutnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"2140_CR1","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1200\/jco.23.01030","volume":"42","author":"JM Unger","year":"2024","unstructured":"Unger JM, Shulman LN, Facktor MA, Nelson H, Fleury ME (2024) National estimates of the participation of patients with cancer in clinical research studies based on Commission on Cancer accreditation data. J Clin Oncol 42:2139\u20132148. https:\/\/doi.org\/10.1200\/jco.23.01030","journal-title":"J Clin Oncol"},{"key":"2140_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cncr.23157","volume":"112","author":"JG Ford","year":"2008","unstructured":"Ford JG, Howerton MW, Lai GY et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112:228\u2013242. https:\/\/doi.org\/10.1002\/cncr.23157","journal-title":"Cancer"},{"key":"2140_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6905","volume":"13","author":"MW Donzo","year":"2024","unstructured":"Donzo MW, Nguyen G, Nemeth JK et al (2024) Effects of socioeconomic status on enrollment in clinical trials for cancer: a systematic review. Cancer Med 13:e6905. https:\/\/doi.org\/10.1002\/cam4.6905","journal-title":"Cancer Med"},{"key":"2140_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.27792","volume":"4","author":"CP Williams","year":"2021","unstructured":"Williams CP, Senft Everson N, Shelburne N, Norton WE (2021) Demographic and health behavior factors associated with clinical trial invitation and participation in the United States. JAMA Netw Open 4:e2127792. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.27792","journal-title":"JAMA Netw Open"},{"key":"2140_CR5","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.1200\/op.22.00325","volume":"19","author":"SJ Grant","year":"2023","unstructured":"Grant SJ, Jansen M, Kuo TM et al (2023) Cross-sectional analysis of clinical trial availability and North Carolina neighborhood social vulnerability. JCO Oncol Pract 19:e248\u2013e262. https:\/\/doi.org\/10.1200\/op.22.00325","journal-title":"JCO Oncol Pract"},{"key":"2140_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-024-00586-9","volume":"4","author":"JY Kim","year":"2024","unstructured":"Kim JY, Florez M, Botto E, Belgrave X, Grace C, Getz K (2024) The influence of socioeconomic status on individual attitudes and experience with clinical trials. Commun Med 4:172. https:\/\/doi.org\/10.1038\/s43856-024-00586-9","journal-title":"Commun Med"},{"key":"2140_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.46494","volume":"6","author":"W Khadraoui","year":"2023","unstructured":"Khadraoui W, Meade CE, Backes FJ, Felix AS (2023) Racial and ethnic disparities in clinical trial enrollment among women with gynecologic cancer. JAMA Netw Open 6:e2346494. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.46494","journal-title":"JAMA Netw Open"},{"key":"2140_CR8","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/hex.13726","volume":"26","author":"AL Tamlyn","year":"2023","unstructured":"Tamlyn AL, Tjilos M, Bosch NA et al (2023) At the intersection of trust and mistrust: a qualitative analysis of motivators and barriers to research participation at a safety-net hospital. Health Expect 26:1118\u20131126. https:\/\/doi.org\/10.1111\/hex.13726","journal-title":"Health Expect"},{"key":"2140_CR9","doi-asserted-by":"publisher","unstructured":"Smirnoff M, Wilets I, Ragin DF, Adams R, Holohan J, Rhodes R, Winkel G, Ricci EM, Clesca C, Richardson LD (2018) A paradigm for understanding trust and mistrust in medical research: The Community VOICES study. AJOB Empir Bioeth 9(1):39\u201347. https:\/\/doi.org\/10.1080\/23294515.2018.1432718.","DOI":"10.1080\/23294515.2018.1432718"},{"key":"2140_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/20552076251325581","volume":"11","author":"GB Rocque","year":"2025","unstructured":"Rocque GB, Henderson NL, Hildreth K et al (2025) Exploration of digital health literacy among community members and healthcare teams in the deep south: a quasi-experimental study. Digit Health 11:20552076251325581. https:\/\/doi.org\/10.1177\/20552076251325581","journal-title":"Digit Health"},{"key":"2140_CR11","doi-asserted-by":"publisher","unstructured":"Pope CN, Stavrinos D, Fazeli PL, Vance DE (2022) Transportation barriers and health-related quality of life in a sample of middle-aged and older adults living with HIV in the deep south. AIDS Behav 26(7):2148\u20132158. https:\/\/doi.org\/10.1007\/s10461-021-03560-x","DOI":"10.1007\/s10461-021-03560-x"},{"key":"2140_CR12","unstructured":"Katsinas SK et al (2023) Internet access disparities in Alabama & the Black Belt (issue brief). Education Policy Center: University of Alabama"},{"key":"2140_CR13","unstructured":"Bureau USC. (2021) Population Estimates, July 1, 2021 (V2021)\u2014Montgomery County, Alabama; Marengo County, Alabama; Macon County, Alabama; Lowndes County, Alabama; Hale County, Alabama; Greene County, Alabama. Suitland-Silver Hill: U.S. Census Bureau"},{"key":"2140_CR14","unstructured":"Bureau USC. (2021) Population Estimates, July 1, 2021 (V2021)\u2014Wilcox County, Alabama; Sumter County, Alabama; Russell County, Alabama; Pike County, Alabama; Pickens County, Alabama; Perry County, Alabama; Quick Facts. Suitland-Silver Hill: U.S. Census Bureau"},{"key":"2140_CR15","unstructured":"Bureau USC (2021) Population Estimates, July 1, 2021 (V2021)\u2014Dallas County, Alabama; Crenshaw County, Alabama; Choctaw County, Alabama; Butler County, Alabama; Bullock County, Alabama; Barbour County, Alabama. Suitland-Silver Hill: U.S. Census Bureau"},{"key":"2140_CR16","unstructured":"Bureau USC (2021) Population Estimates, July 1, 2021 (V2021)\u2014Dallas County, Alabama; Crenshaw County, Alabama; Choctaw County, Alabama; Butler County, Alabama; Bullock County, Alabama; Barbour County, Alabama; Quick Facts. Suitland-Silver Hill, MD: U.S. Census Bureau"},{"key":"2140_CR17","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/jamaoncol.2015.6487","volume":"2","author":"JM Unger","year":"2016","unstructured":"Unger JM, Barlow WE, Ramsey SD, LeBlanc M, Blanke CD, Hershman DL (2016) The scientific impact of positive and negative phase 3 cancer clinical trials. JAMA Oncol 2:875\u2013881. https:\/\/doi.org\/10.1001\/jamaoncol.2015.6487","journal-title":"JAMA Oncol"},{"key":"2140_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1200\/edbk_156686","volume":"35","author":"JM Unger","year":"2016","unstructured":"Unger JM, Cook E, Tai E, Bleyer A (2016) The role of clinical trial participation in cancer research: barriers, evidence, and strategies. Am Soc Clin Oncol Educ Book 35:185\u2013198. https:\/\/doi.org\/10.1200\/edbk_156686","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2140_CR19","doi-asserted-by":"publisher","DOI":"10.1200\/edbk_179803","author":"EH Rubin","year":"2017","unstructured":"Rubin EH, Scroggins MJ, Goldberg KB, Beaver JA (2017) Strategies to maximize patient participation in clinical trials. Am Soc Clin Oncol Educ Bk. https:\/\/doi.org\/10.1200\/edbk_179803","journal-title":"Am Soc Clin Oncol Educ Bk"},{"key":"2140_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s40290-022-00458-4","volume":"37","author":"SD Faulkner","year":"2023","unstructured":"Faulkner SD, Somers F, Boudes M, Nafria B, Robinson P (2023) Using patient perspectives to inform better clinical trial design and conduct: current trends and future directions. Pharm Med 37:129\u2013138. https:\/\/doi.org\/10.1007\/s40290-022-00458-4","journal-title":"Pharm Med"},{"key":"2140_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1258\/jhsrp.2008.008028","volume":"13","author":"I de Salis","year":"2008","unstructured":"de Salis I, Tomlin Z, Toerien M, Donovan J (2008) Using qualitative research methods to improve recruitment to randomized controlled trials: the quartet study. J Health Serv Res Policy 13:92\u201396. https:\/\/doi.org\/10.1258\/jhsrp.2008.008028","journal-title":"J Health Serv Res Policy"},{"key":"2140_CR22","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1245\/s10434-024-16607-9","volume":"32","author":"N Reh","year":"2025","unstructured":"Reh N, Caston NE, Williams CP et al (2025) Therapeutic clinical trial eligibility and enrollment among women with breast cancer: implications for understanding trial disparities. Ann Surg Oncol 32:2038\u20132044. https:\/\/doi.org\/10.1245\/s10434-024-16607-9","journal-title":"Ann Surg Oncol"},{"key":"2140_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/16094069241296206","volume":"23","author":"A Wutich","year":"2024","unstructured":"Wutich A, Beresford M, Bernard HR (2024) Sample sizes for 10 types of qualitative data analysis: an integrative review, empirical guidance, and next steps. Int J Qual Methods 23:16094069241296206. https:\/\/doi.org\/10.1177\/16094069241296206","journal-title":"Int J Qual Methods"},{"key":"2140_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 19:349\u2013357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042","journal-title":"Int J Qual Health Care"},{"key":"2140_CR25","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","volume":"378","author":"AJH Kind","year":"2018","unstructured":"Kind AJH, Buckingham WR (2018) Making neighborhood-disadvantage metrics accessible - the Neighborhood Atlas. N Engl J Med 378:2456\u20132458. https:\/\/doi.org\/10.1056\/NEJMp1802313","journal-title":"N Engl J Med"},{"key":"2140_CR26","doi-asserted-by":"publisher","DOI":"10.1200\/edbk_389838","author":"A Acu\u00f1a-Villaordu\u00f1a","year":"2023","unstructured":"Acu\u00f1a-Villaordu\u00f1a A, Baranda JC, Boehmer J, Fashoyin-Aje L, Gore SD (2023) Equitable access to clinical trials: how do we achieve it? Am Soc Clin Oncol Educ Bk. https:\/\/doi.org\/10.1200\/edbk_389838","journal-title":"Am Soc Clin Oncol Educ Bk"},{"key":"2140_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta12100","volume":"12","author":"J Raftery","year":"2008","unstructured":"Raftery J, Bryant J, Powell J, Kerr C, Hawker S (2008) Payment to healthcare professionals for patient recruitment to trials: systematic review and qualitative study. Health Technol Assess 12:1\u2013128. https:\/\/doi.org\/10.3310\/hta12100","journal-title":"Health Technol Assess"},{"key":"2140_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4065\/84.3.243","volume":"84","author":"A Sood","year":"2009","unstructured":"Sood A, Prasad K, Chhatwani L et al (2009) Patients\u2019 attitudes and preferences about participation and recruitment strategies in clinical trials. Mayo Clin Proc 84:243\u2013247. https:\/\/doi.org\/10.4065\/84.3.243","journal-title":"Mayo Clin Proc"},{"key":"2140_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/1355819613483126","volume":"18","author":"S McCann","year":"2013","unstructured":"McCann S, Campbell M, Entwistle V (2013) Recruitment to clinical trials: a meta-ethnographic synthesis of studies of reasons for participation. J Health Serv Res Policy 18:233\u2013241. https:\/\/doi.org\/10.1177\/1355819613483126","journal-title":"J Health Serv Res Policy"},{"key":"2140_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a2079","volume":"337","author":"U Menon","year":"2008","unstructured":"Menon U, Gentry-Maharaj A, Ryan A et al (2008) Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study. BMJ 337:a2079. https:\/\/doi.org\/10.1136\/bmj.a2079","journal-title":"BMJ"},{"key":"2140_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/20542704231166621","volume":"14","author":"R Dobra","year":"2023","unstructured":"Dobra R, Wilson G, Matthews J et al (2023) A systematic review to identify and collate factors influencing patient journeys through clinical trials. JRSM Open 14:20542704231166621. https:\/\/doi.org\/10.1177\/20542704231166621","journal-title":"JRSM Open"},{"key":"2140_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1158\/1940-6207.Capr-21-0593","volume":"15","author":"JE McGuinness","year":"2022","unstructured":"McGuinness JE, Bhatkhande G, Amenta J et al (2022) Strategies to identify and recruit women at high risk for breast cancer to a randomized controlled trial of web-based decision support tools. Cancer Prev Res (Phila) 15:399\u2013406. https:\/\/doi.org\/10.1158\/1940-6207.Capr-21-0593","journal-title":"Cancer Prev Res (Phila)"},{"key":"2140_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1200\/jop.0922001","volume":"5","author":"RL Comis","year":"2009","unstructured":"Comis RL, Miller JD, Colaizzi DD, Kimmel LG (2009) Physician-related factors involved in patient decisions to enroll onto cancer clinical trials. J Oncol Pract 5:50\u201356. https:\/\/doi.org\/10.1200\/jop.0922001","journal-title":"J Oncol Pract"},{"key":"2140_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s13187-017-1261-0","volume":"34","author":"SJ Niranjan","year":"2019","unstructured":"Niranjan SJ, Durant RW, Wenzel JA et al (2019) Training needs of clinical and research professionals to optimize minority recruitment and retention in cancer clinical trials. J Cancer Educ 34:26\u201334. https:\/\/doi.org\/10.1007\/s13187-017-1261-0","journal-title":"J Cancer Educ"},{"key":"2140_CR35","doi-asserted-by":"publisher","first-page":"e570","DOI":"10.1200\/op.22.00378","volume":"19","author":"NJ Barrett","year":"2023","unstructured":"Barrett NJ, Boehmer L, Schrag J et al (2023) An assessment of the feasibility and utility of an ACCC-ASCO implicit bias training program to enhance racial and ethnic diversity in cancer clinical trials. JCO Oncol Pract 19:e570\u2013e580. https:\/\/doi.org\/10.1200\/op.22.00378","journal-title":"JCO Oncol Pract"},{"key":"2140_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0027-9684(15)30261-3","volume":"103","author":"RW Durant","year":"2011","unstructured":"Durant RW, Legedza AT, Marcantonio ER, Freeman MB, Landon BE (2011) Different types of distrust in clinical research among whites and African Americans. J Natl Med Assoc 103:123\u2013130. https:\/\/doi.org\/10.1016\/s0027-9684(15)30261-3","journal-title":"J Natl Med Assoc"},{"issue":"7","key":"2140_CR37","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/cncr.28570","volume":"120","author":"RG Ghebre","year":"2014","unstructured":"Ghebre RG, Jones LA, Wenzel JA, Martin MY, Durant RW, Ford JG (2014) State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual. Cancer 120(7):1122\u20131130. https:\/\/doi.org\/10.1002\/cncr.28570","journal-title":"Cancer"},{"key":"2140_CR38","unstructured":"National Academies of Sciences E, Medicine (2025) Toward a framework to improve diversity and inclusion in clinical trials: proceedings of a workshop. Washington, DC: The National Academies Press."},{"key":"2140_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.conctc.2016.04.005","volume":"3","author":"KB Cartmell","year":"2016","unstructured":"Cartmell KB, Bonilha HS, Matson T et al (2016) Patient participation in cancer clinical trials: a pilot test of lay navigation. Contemp Clin Trials Commun 3:86\u201393. https:\/\/doi.org\/10.1016\/j.conctc.2016.04.005","journal-title":"Contemp Clin Trials Commun"},{"key":"2140_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2020.100532","volume":"17","author":"JM Regnante","year":"2020","unstructured":"Regnante JM, Richie N, Fashoyin-Aje L et al (2020) Operational strategies in US cancer centers of excellence that support the successful accrual of racial and ethnic minorities in clinical trials. Contemp Clin Trials Commun 17:100532. https:\/\/doi.org\/10.1016\/j.conctc.2020.100532","journal-title":"Contemp Clin Trials Commun"},{"key":"2140_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-018-2578-7","volume":"19","author":"S Chhatre","year":"2018","unstructured":"Chhatre S, Jefferson A, Cook R et al (2018) Patient-centered recruitment and retention for a randomized controlled study. Trials 19:205. https:\/\/doi.org\/10.1186\/s13063-018-2578-7","journal-title":"Trials"},{"key":"2140_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cpcardiol.2018.11.002","volume":"44","author":"LT Clark","year":"2019","unstructured":"Clark LT, Watkins L, Pi\u00f1a IL et al (2019) Increasing diversity in clinical trials: overcoming critical barriers. Curr Probl Cardiol 44:148\u2013172. https:\/\/doi.org\/10.1016\/j.cpcardiol.2018.11.002","journal-title":"Curr Probl Cardiol"},{"key":"2140_CR43","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/1357633x211017805","volume":"29","author":"S Sabesan","year":"2023","unstructured":"Sabesan S, Malica M, Gebbie C, Scott C, Thomas D, Zalcberg J (2023) Implementation of the Australasian teletrial model: translating ideas into action using implementation science frameworks. J Telemed Telecare 29:641\u2013647. https:\/\/doi.org\/10.1177\/1357633x211017805","journal-title":"J Telemed Telecare"},{"key":"2140_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-024-00658-x","author":"T Symons","year":"2024","unstructured":"Symons T, Woollett A, Zalcberg J, Eckstein L (2024) Implementing decentralized clinical trials in Australia through teletrials: where to from here? Ther Innov Regul Sci. https:\/\/doi.org\/10.1007\/s43441-024-00658-x","journal-title":"Ther Innov Regul Sci"},{"key":"2140_CR45","doi-asserted-by":"publisher","first-page":"601","DOI":"10.62347\/spvk4847","volume":"15","author":"M Santiago-Torres","year":"2025","unstructured":"Santiago-Torres M, Westmaas JL, Ostroff JS et al (2025) Overcoming challenges of recruiting cancer patients into clinical trials: insights from a randomized trial of app-based smoking cessation interventions. Am J Cancer Res. 15:601\u201317. https:\/\/doi.org\/10.62347\/spvk4847","journal-title":"Am J Cancer Res."},{"key":"2140_CR46","unstructured":"Adams B (2021)  Diversity and inclusion in clinical research [podcast on the Internet]. In: The next phase: rxploring innovation in clinical trials. Florence Healthcare. Available from: https:\/\/podcasts.apple.com\/il\/podcast\/diversity-and-inclusion-in-clinical-research\/id1553956771?i=1000517335159"},{"key":"2140_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00520-021-06407-2","volume":"30","author":"Z Moon","year":"2022","unstructured":"Moon Z, Zuchowski M, Moss-Morris R, Hunter MS, Norton S, Hughes LD (2022) Disparities in access to mobile devices and e-health literacy among breast cancer survivors. Support Care Cancer 30:117\u2013126. https:\/\/doi.org\/10.1007\/s00520-021-06407-2","journal-title":"Support Care Cancer"},{"key":"2140_CR48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13195-016-0201-2","volume":"8","author":"R Banzi","year":"2016","unstructured":"Banzi R, Camaioni P, Tettamanti M, Bertele V, Lucca U (2016) Older patients are still under-represented in clinical trials of Alzheimer\u2019s disease. Alzheimer\u2019s Res Therap 8:32. https:\/\/doi.org\/10.1186\/s13195-016-0201-2","journal-title":"Alzheimer\u2019s Res Therap"},{"key":"2140_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-024-08665-x","volume":"25","author":"M Iflaifel","year":"2024","unstructured":"Iflaifel M, Hall CL, Green HR et al (2024) Strategies to improve recruitment in mental health clinical trials: a scoping review (RE-MIND study). Trials 25:832. https:\/\/doi.org\/10.1186\/s13063-024-08665-x","journal-title":"Trials"},{"key":"2140_CR50","doi-asserted-by":"publisher","DOI":"10.2196\/22179","volume":"22","author":"M Br\u00f8gger-Mikkelsen","year":"2020","unstructured":"Br\u00f8gger-Mikkelsen M, Ali Z, Zibert JR, Andersen AD, Thomsen SF (2020) Online patient recruitment in clinical trials: systematic review and meta-analysis. J Med Internet Res 22:e22179. https:\/\/doi.org\/10.2196\/22179","journal-title":"J Med Internet Res"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02140-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-026-02140-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02140-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:59:50Z","timestamp":1773392390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-026-02140-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2140"],"URL":"https:\/\/doi.org\/10.1007\/s10552-026-02140-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7963137\/v1","asserted-by":"object"}]},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors Mandy Chen, Nikki Reh, Sindhu Dwarampudi, and Nicole Henderson declare they have no financial interests. Author Courtney P. Williams discloses research funding from Flatiron Health. Author Gabrielle B. Rocque discloses research funding from Pfizer, Genentech, and Daiichi Sankyo, and serves as consultant for Armada, Gilead, and Pfizer. Author Lily Gutnik serves as a consultant for Daiichi Sankyo.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the UAB Institutional Review Board for Human Use (IRB-300001910).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"52"}}